Expression and release of CD27 in human B-cell malignancies.

Abstract:

:CD27, a transmembrane disulfide-linked 55-kD homodimer, belongs to the nerve growth factor-receptor family, a group of homologous molecules involved in lymphocyte differentiation and selection. It is expressed on mature thymocytes, peripheral blood T cells, and a subpopulation of B cells. We investigated the expression of CD27 on malignant B cells representative for a broad range of stages in physiologic antigen-independent and -dependent B-cell development. In normal lymphoid tissue CD27+ B cells were only found in the peripheral blood (29.8% +/- 10.8%, n = 13) and in germinal centers. With the exception of pro-B and the majority of pre-pre-B acute lymphocytic leukemias and of myelomas, CD27 expression of variable intensity was detected on almost all immature and mature malignant B cells tested. Moreover, using a sandwich enzyme-linked immunosorbent assay we could show the presence of sometimes very high (up to 6,000 U/mL; normal values < 190 U/mL) amounts of the soluble 28- to 32-kD form of CD27 (sCD27) in the sera of patients with B-cell malignancies. The highest levels of sCD27 were observed in patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphomas. Most importantly, both in transversal and longitudinal studies, we found a strong correlation between sCD27 levels in the serum and tumor load, indicating that sCD27 can be used as a disease-marker in patients with acute and chronic B-cell malignancies.

journal_name

Blood

journal_title

Blood

authors

van Oers MH,Pals ST,Evers LM,van der Schoot CE,Koopman G,Bonfrer JM,Hintzen RQ,von dem Borne AE,van Lier RA

subject

Has Abstract

pub_date

1993-12-01 00:00:00

pages

3430-6

issue

11

eissn

0006-4971

issn

1528-0020

journal_volume

82

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.

    abstract::The interplay between bone marrow stromal cells (BMSCs) and multiple myeloma (MM) cells performs a crucial role in MM pathogenesis by secreting growth factors, cytokines, and extracellular vesicles. Exosomes are membranous vesicles 40 to 100 nm in diameter constitutively released by almost all cell types, and they med...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-03-562439

    authors: Wang J,Hendrix A,Hernot S,Lemaire M,De Bruyne E,Van Valckenborgh E,Lahoutte T,De Wever O,Vanderkerken K,Menu E

    更新日期:2014-07-24 00:00:00

  • New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases.

    abstract::A large number of alterations in genes encoding receptor tyrosine kinase (RTK), namely FLT3, c-KIT, platelet-derived growth factor (PDGF) receptors, fibroblast growth factor (FGF) receptors, and the anaplastic large cell lymphoma kinase (ALK), have been found in hematopoietic malignancies. They have drawn much attenti...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-04-279752

    authors: Toffalini F,Demoulin JB

    更新日期:2010-10-07 00:00:00

  • A test for Fanconi's anemia.

    abstract::A simple and reliable cytogenetic test for Fanconi's anemia (FA) that is based on the hypersensitivity of FA cells to mitomycin C (MC) is described. Equal volumes of whole blood from a patient in whom the diagnosis of FA is suspected and from a normal person of the opposite sex are co-cultured in phytohemagglutinin-co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: German J,Schonberg S,Caskie S,Warburton D,Falk C,Ray JH

    更新日期:1987-06-01 00:00:00

  • Infection of CD34(+) hematopoietic progenitor cells by human herpesvirus 7 (HHV-7).

    abstract::To investigate the tropism of the T-lymphotropic human herpesvirus 7 (HHV-7) for hematopoietic progenitors, cord blood CD34(+) cells were inoculated in vitro with HHV-7 and then induced to differentiate along the granulocytic and erythroid lineages by the addition of appropriate cytokine cocktails. In semisolid assays...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mirandola P,Secchiero P,Pierpaoli S,Visani G,Zamai L,Vitale M,Capitani S,Zauli G

    更新日期:2000-07-01 00:00:00

  • Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.

    abstract::Toll-like receptors (TLRs) and complement are 2 components of innate immunity that are critical for first-line host defense and elicitation of adaptive immune responses. Many pathogen-associated molecular patterns activate both TLR and complement, but whether and how these 2 systems, when coactivated in vivo, interact...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-12-063636

    authors: Zhang X,Kimura Y,Fang C,Zhou L,Sfyroera G,Lambris JD,Wetsel RA,Miwa T,Song WC

    更新日期:2007-07-01 00:00:00

  • Follicular helper T-cell-related lymphomas.

    abstract::In this issue of Blood, Wang et al describe the occurrence and pathogenetic relevance of IDH2R172 mutations in angioimmunoblastic T-cell lymphoma (AITL). ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-08-665075

    authors: Pileri SA

    更新日期:2015-10-08 00:00:00

  • Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases.

    abstract::The signals that mediate T-cell infiltration during T-cell autoimmune diseases are poorly understood. The chemokine CCL21 (originally isolated by us and others as Exodus-2/6Ckine/SLC/TCA4) is highly potent and highly specific for stimulating T-cell migration. However, it is thought to be expressed only in secondary ly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1586

    authors: Christopherson KW 2nd,Hood AF,Travers JB,Ramsey H,Hromas RA

    更新日期:2003-02-01 00:00:00

  • In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin.

    abstract::Various abnormalities of lymphokine production have been described in patients with aplastic anemia. To determine if abnormal production of hematopoietic growth factors could contribute to the process of aplastic anemia we studied the in vitro production of human granulocyte-macrophage colony-stimulating factor (GM-CS...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nimer SD,Golde DW,Kwan K,Lee K,Clark S,Champlin R

    更新日期:1991-07-01 00:00:00

  • Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.

    abstract::Fifty-eight acute promyelocytic leukemia (APL) patients (11 newly diagnosed and 47 relapsed) were studied for arsenic trioxide (As2O3) treatment. Clinical complete remission (CR) was obtained in 8 of 11 (72.7%) newly diagnosed cases. However, As2O3 treatment resulted in hepatic toxicity in 7 cases including 2 deaths, ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Niu C,Yan H,Yu T,Sun HP,Liu JX,Li XS,Wu W,Zhang FQ,Chen Y,Zhou L,Li JM,Zeng XY,Yang RR,Yuan MM,Ren MY,Gu FY,Cao Q,Gu BW,Su XY,Chen GQ,Xiong SM,Zhang TD,Waxman S,Wang ZY,Chen Z,Hu J,Shen ZX,Chen SJ

    更新日期:1999-11-15 00:00:00

  • Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.

    abstract::Expression of vascular endothelial growth factor (VEGF) is tightly regulated to achieve normal angiogenesis. The objective was to examine regulation of VEGF by the activin-like kinase receptors (ALKs) ALK1 and ALK5. Transforming growth factor beta1 (TGFbeta1) and bone morphogenetic protein-9 (BMP-9) enhanced and suppr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-199166

    authors: Shao ES,Lin L,Yao Y,Boström KI

    更新日期:2009-09-03 00:00:00

  • Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

    abstract::Most anticancer chemotherapies are immunosuppressive and induce nonimmunogenic tumor cell death. Bortezomib, a specific inhibitor of 26S proteasome, has shown clinical activity in several human tumors, including myeloma. Here we show that the uptake of human myeloma cells by dendritic cells (DCs) after tumor cell deat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-054221

    authors: Spisek R,Charalambous A,Mazumder A,Vesole DH,Jagannath S,Dhodapkar MV

    更新日期:2007-06-01 00:00:00

  • Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized tria

    abstract::From 1990 to 1996, a total of 386 adult patients with early/intermediate Hodgkin disease (HD) were randomly assigned to receive 3 cycles of adriamycin, bleomycin, vinblastine, dacarbazine (an alkylating agent), and methylprednisolone (ABVDm, arm A) or epirubicin, bleomycin, vinblastine, methotrexate, and methylprednis...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2003-05-1611

    authors: le Maignan C,Desablens B,Delwail V,Dib M,Berthou C,Vigier M,Ghandour C,Atmani S,Casassus P,Maisonneuve H,Le Mevel A,Traulle C,Bernard M,Briere J,Colonna P,Andrieu JM

    更新日期:2004-01-01 00:00:00

  • Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.

    abstract::The plasminogen activator inhibitor PAI-1 is markedly elevated in vivo and in vitro upon exposure to the inflammatory mediators tumor necrosis factor alpha (TNF alpha), interleukin-1 (IL-1), and bacterial lipopolysaccharide. Here we report that the isoflavone compound genistein prevents the increase in synthesis of PA...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Hinsbergh VW,Vermeer M,Koolwijk P,Grimbergen J,Kooistra T

    更新日期:1994-11-01 00:00:00

  • Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

    abstract::Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation vi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Koppelman SJ,Hackeng TM,Sixma JJ,Bouma BN

    更新日期:1995-08-01 00:00:00

  • Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.

    abstract::Sickle cell disease (SCD) is characterized by a single point mutation in the seventh codon of the β-globin gene. Site-specific correction of the sickle mutation in hematopoietic stem cells would allow for permanent production of normal red blood cells. Using zinc-finger nucleases (ZFNs) designed to flank the sickle mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-12-615948

    authors: Hoban MD,Cost GJ,Mendel MC,Romero Z,Kaufman ML,Joglekar AV,Ho M,Lumaquin D,Gray D,Lill GR,Cooper AR,Urbinati F,Senadheera S,Zhu A,Liu PQ,Paschon DE,Zhang L,Rebar EJ,Wilber A,Wang X,Gregory PD,Holmes MC,Reik A

    更新日期:2015-04-23 00:00:00

  • Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1.

    abstract::To investigate the role of peritoneal mesothelial cells in regulating hematopoiesis, as well as inflammation, healing, and tissue regeneration processes, long-term cultures of peritoneal mesothelial cells from human endocavitarian fluids were established. The purity of the cell population was assessed by morphologic a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lanfrancone L,Boraschi D,Ghiara P,Falini B,Grignani F,Peri G,Mantovani A,Pelicci PG

    更新日期:1992-12-01 00:00:00

  • Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells.

    abstract::The molecular mechanisms by which mesenchymal stem cells (MSCs) suppress T-cell proliferation are poorly understood, and whether a soluble factor plays a major role remains controversial. Here we demonstrate that the T-cell-receptor complex is not a target for the suppression, suggesting that downstream signals mediat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-02-002246

    authors: Sato K,Ozaki K,Oh I,Meguro A,Hatanaka K,Nagai T,Muroi K,Ozawa K

    更新日期:2007-01-01 00:00:00

  • Transplant strategies in relapsed/refractory Hodgkin lymphoma.

    abstract::The majority of patients with Hodgkin lymphoma (HL) are cured with initial therapy. However, high-dose therapy with autologous hematopoietic cell transplant (AHCT) allows for the cure of an additional portion of patients with relapsed or primary refractory disease. Positron emission tomography-negative complete remiss...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-09-772673

    authors: Shah GL,Moskowitz CH

    更新日期:2018-04-12 00:00:00

  • Ethical considerations in genomic testing for hematologic disorders.

    abstract::As our technological capacities improve, genomic testing is increasingly integrating into patient care. The field of clinical hematology is no exception. Genomic testing carries great promise, but several ethical issues must be considered whenever such testing is performed. This review addresses these ethical consider...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-01-734558

    authors: Marron JM,Joffe S

    更新日期:2017-07-27 00:00:00

  • Structure-function relationships of stem cell factor: an analysis based on a series of human-murine stem cell factor chimera and the mapping of a neutralizing monoclonal antibody.

    abstract::Although much is now known about the biological properties of the c-kit receptor and its ligand, stem cell factor (SCF), little is known of the structural basis for the binding and function of this hematopoietic cytokine. By analyzing the activities of chimeric interspecies and homologue muteins and epitope mapping of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Matous JV,Langley K,Kaushansky K

    更新日期:1996-07-15 00:00:00

  • B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy.

    abstract::Characterization of lymphocytes including B cells during early versus chronic HIV infection is important for understanding the impact of chronic viremia on immune cell function. In this setting, we investigated B cells before and after reduction of HIV plasma viremia by antiretroviral therapy (ART). At baseline, perip...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-285528

    authors: Moir S,Buckner CM,Ho J,Wang W,Chen J,Waldner AJ,Posada JG,Kardava L,O'Shea MA,Kottilil S,Chun TW,Proschan MA,Fauci AS

    更新日期:2010-12-16 00:00:00

  • Vav proteins regulate peripheral B-cell survival.

    abstract::Mice lacking all 3 Vav proteins fail to produce significant numbers of recirculating follicular or marginal zone B cells. Those B cells that do mature have shortened lifespans. The constitutive nuclear factor-kappaB (NF-kappaB) activity of resting naive B cells required Vav function and expression of cellular reticulo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-12-4894

    authors: Vigorito E,Gambardella L,Colucci F,McAdam S,Turner M

    更新日期:2005-10-01 00:00:00

  • Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers.

    abstract::Although hepatitis C virus (HCV) mainly affects hepatocytes, infection is widespread and involves immunologically privileged sites. Whether lymphoid cells represent further targets of early HCV infection, or whether other cells in the hematopoietic microenvironment may serve as a potential virus reservoir, is still un...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sansonno D,Lotesoriere C,Cornacchiulo V,Fanelli M,Gatti P,Iodice G,Racanelli V,Dammacco F

    更新日期:1998-11-01 00:00:00

  • T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.

    abstract::T-cell depletion (TCD) of the donor marrow graft has been shown to reduce the severity of graft-versus-host disease (GVHD) in patients with chronic-phase (CP) chronic myelogenous leukemia (CML) undergoing HLA-identical sibling allogeneic marrow transplantation. However, there has been a corresponding reduction in the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Drobyski WR,Hessner MJ,Klein JP,Kabler-Babbitt C,Vesole DH,Margolis DA,Keever-Taylor CA

    更新日期:1999-07-15 00:00:00

  • Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications.

    abstract::Although the binding of endothelial cell protein C receptor (EPCR) to its ligands is well characterized at the biochemical level, it remains unclear how EPCR interaction with its ligands at the cell surface impacts its cellular trafficking. We characterized the cellular localization and trafficking of EPCR in endothel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208900

    authors: Nayak RC,Sen P,Ghosh S,Gopalakrishnan R,Esmon CT,Pendurthi UR,Rao LV

    更新日期:2009-08-27 00:00:00

  • C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.

    abstract::Cellular oncogenes have been localized at the breakpoints of characteristic chromosomal rearrangements occurring in certain hematologic malignancies. This has been reported to result in aberrant expression of the involved oncogenes. Over 90% of chronic myelogenous leukemia (CML) is characterized by a reciprocal transl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Romero P,Blick M,Talpaz M,Murphy E,Hester J,Gutterman J

    更新日期:1986-03-01 00:00:00

  • Ex vivo characterization and isolation of rare memory B cells with antigen tetramers.

    abstract::Studying human antigen-specific memory B cells has been challenging because of low frequencies in peripheral blood, slow proliferation, and lack of antibody secretion. Therefore, most studies have relied on conversion of memory B cells into antibody-secreting cells by in vitro culture. To facilitate direct ex vivo iso...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341917

    authors: Franz B,May KF Jr,Dranoff G,Wucherpfennig K

    更新日期:2011-07-14 00:00:00

  • Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics.

    abstract::Overwhelming evidence from leukemia research has shown that the clonal population of neoplastic cells exhibits marked heterogeneity with respect to proliferation and differentiation. There are rare stem cells within the leukemic population that possess extensive proliferation and self-renewal capacity not found in the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-07-2514

    authors: Fang B,Zheng C,Liao L,Han Q,Sun Z,Jiang X,Zhao RC

    更新日期:2005-04-01 00:00:00

  • Retinoic acid controls blood vessel formation by modulating endothelial and mural cell interaction via suppression of Tie2 signaling in vascular progenitor cells.

    abstract::Inhibition by all-trans retinoic acid (atRA) of the microvasculature formation in chicken chorioallantoic membrane (CAM) accompanied remarkably reduced numbers of endothelial cells (ECs) and increased numbers of mural cells (MCs) under the chorionic epithelial layer. Ro41-5253 (retinoid antagonist) exerted the opposit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-09-3293

    authors: Suzuki Y,Komi Y,Ashino H,Yamashita J,Inoue J,Yoshiki A,Eichmann A,Amanuma H,Kojima S

    更新日期:2004-07-01 00:00:00

  • NHERF-2 silences the silencers.

    abstract::Hyperresponsiveness to growth factors underlies a wide variety of human diseases,including hemangiomas, the most common tumor of childhood. Hemangiomas have been found to be clonal neoplasms of endothelial cells, with somatic mutations in unknown genes likely to be responsible for their development. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-04-415059

    authors: Arbiser JL

    更新日期:2012-05-17 00:00:00